ArticleBritish journal of haematology2024

Deferasirox, an iron chelator, impacts myeloid differentiation by modulating NF-kB activity via mitochondrial ROS.

Nathan E Jeffries et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.